Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center.


Journal

Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 13 01 2019
accepted: 11 06 2019
pubmed: 27 6 2019
medline: 28 10 2020
entrez: 26 6 2019
Statut: ppublish

Résumé

The National Cardiovascular Data Registry (NCDR) risk scores for mortality, bleeding and acute kidney injury (AKI) are accurate outcome predictors of coronary catheterization procedures in North American populations. However, their application in German clinical practice remained elusive and we thus aimed to verify their use. NCDR scores for mortality, bleeding and AKI and corresponding clinical outcomes were retrospectively assessed in patients undergoing catheterization for ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) or for elective coronary procedures at a German Heart Center from 2014 to 2017. Risk model performance was assessed using receiver-operating-characteristic curves (discrimination) and graphical analysis/logistic regression (calibration). A total of 1637 patients were included, procedures were performed for STEMI (565 patients, 34.5%), NSTEMI (572 patients, 34.9%) and elective purposes (500 patients, 30.5%); 6% (13% of STEMI and 5% of NSTEMI patients) presented in cardiogenic shock and 3% with resuscitated cardiac arrest. Radial access was used in 38% of procedures and cross-over was necessary in 5%; PCI was performed in 60% of procedures. In-hospital mortality was 6.3% (STEMI 14.5%; NSTEMI 3.7%; elective 0%) and major bleedings occurred in 5.6% (STEMI 10.6%; NSTEMI 5.4%; elective 0.2%); AKI was detected in 18.1% of patients (STEMI 23.7%; NSTEMI 27.3%; elective 1.4%), amounting to KDIGO stage I/II/III in 11.5%/3.5%/3.2%. NCDR risk models discriminated very well for mortality [AUC 0.93 with 95% confidence interval (CI) 0.91-0.95] and well for major bleeding (AUC 0.82, CI 0.78-0.86) and any AKI (AUC 0.83, CI 0.81-0.86). Discrimination in the subgroup of patients with PCI was comparable (mortality: AUC 0.90; major bleeding: AUC 0.78; any AKI: AUC 0.79). However, calibration showed considerable underestimation of mortality and AKI in high-risk patients, while major bleeding was consistently overestimated (Hosmer-Lemeshow p < 0.02 for all outcomes). The NCDR risk models showed excellent performance in discriminating high-risk from low-risk patients in contemporary German interventional cardiology. Model calibration for adverse event probability prediction, however, is limited and demands recalibration, especially in high-risk patients.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
The National Cardiovascular Data Registry (NCDR) risk scores for mortality, bleeding and acute kidney injury (AKI) are accurate outcome predictors of coronary catheterization procedures in North American populations. However, their application in German clinical practice remained elusive and we thus aimed to verify their use.
METHODS METHODS
NCDR scores for mortality, bleeding and AKI and corresponding clinical outcomes were retrospectively assessed in patients undergoing catheterization for ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) or for elective coronary procedures at a German Heart Center from 2014 to 2017. Risk model performance was assessed using receiver-operating-characteristic curves (discrimination) and graphical analysis/logistic regression (calibration).
RESULTS RESULTS
A total of 1637 patients were included, procedures were performed for STEMI (565 patients, 34.5%), NSTEMI (572 patients, 34.9%) and elective purposes (500 patients, 30.5%); 6% (13% of STEMI and 5% of NSTEMI patients) presented in cardiogenic shock and 3% with resuscitated cardiac arrest. Radial access was used in 38% of procedures and cross-over was necessary in 5%; PCI was performed in 60% of procedures. In-hospital mortality was 6.3% (STEMI 14.5%; NSTEMI 3.7%; elective 0%) and major bleedings occurred in 5.6% (STEMI 10.6%; NSTEMI 5.4%; elective 0.2%); AKI was detected in 18.1% of patients (STEMI 23.7%; NSTEMI 27.3%; elective 1.4%), amounting to KDIGO stage I/II/III in 11.5%/3.5%/3.2%. NCDR risk models discriminated very well for mortality [AUC 0.93 with 95% confidence interval (CI) 0.91-0.95] and well for major bleeding (AUC 0.82, CI 0.78-0.86) and any AKI (AUC 0.83, CI 0.81-0.86). Discrimination in the subgroup of patients with PCI was comparable (mortality: AUC 0.90; major bleeding: AUC 0.78; any AKI: AUC 0.79). However, calibration showed considerable underestimation of mortality and AKI in high-risk patients, while major bleeding was consistently overestimated (Hosmer-Lemeshow p < 0.02 for all outcomes).
CONCLUSIONS CONCLUSIONS
The NCDR risk models showed excellent performance in discriminating high-risk from low-risk patients in contemporary German interventional cardiology. Model calibration for adverse event probability prediction, however, is limited and demands recalibration, especially in high-risk patients.

Identifiants

pubmed: 31236693
doi: 10.1007/s00392-019-01506-x
pii: 10.1007/s00392-019-01506-x
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

235-245

Subventions

Organisme : Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf
ID : Clinician Scientist No. 2018-32

Références

Eur Heart J. 2018 Feb 14;39(7):508-579
pubmed: 29190377
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Rev Port Cardiol. 2016 Feb;35(2):73-8
pubmed: 26839009
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
N Engl J Med. 2009 Sep 10;361(11):1045-57
pubmed: 19717846
J Am Coll Cardiol. 2013 Jan 29;61(4):485-510
pubmed: 23256913
JAMA. 2015 Sep 8;314(10):1063-4
pubmed: 26348755
Ann Intern Med. 2015 Feb 17;162(4):266-75
pubmed: 25686167
Thromb Haemost. 2015 Nov;114(5):933-44
pubmed: 26177601
Circulation. 2011 Dec 6;124(23):e574-651
pubmed: 22064601
Clin Res Cardiol. 2018 Feb;107(2):148-157
pubmed: 28939956
Circulation. 2011 Jun 14;123(23):2736-47
pubmed: 21670242
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215
J Am Heart Assoc. 2014 Dec;3(6):e001380
pubmed: 25516439
J Biomed Inform. 2005 Oct;38(5):367-75
pubmed: 16198996
J Am Coll Cardiol. 2010 May 4;55(18):1923-32
pubmed: 20430263
JACC Cardiovasc Interv. 2013 Aug;6(8):790-9
pubmed: 23968699
Open Heart. 2017 Jul 25;4(2):e000576
pubmed: 28878944
Eur Heart J. 2016 Jan 14;37(3):267-315
pubmed: 26320110
Open Heart. 2015 Feb 10;2(1):e000088
pubmed: 25745565
J Cardiovasc Med (Hagerstown). 2017 Jan;18 Suppl 1:e67-e70
pubmed: 27828826
N Engl J Med. 2007 Nov 15;357(20):2001-15
pubmed: 17982182
Circulation. 2014 Dec 23;130(25):e344-426
pubmed: 25249585
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
N Engl J Med. 2013 Jan 17;368(3):254-65
pubmed: 23323902
J Am Coll Cardiol. 1998 Jul;32(1):275-82
pubmed: 9669281
Circulation. 2012 Mar 27;125(12):1501-10
pubmed: 22361329
Clin Res Cardiol. 2017 Aug;106(8):618-628
pubmed: 28293797
Lancet. 2015 Jun 20;385(9986):2465-76
pubmed: 25791214
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
J Am Coll Cardiol. 1999 Sep;34(3):692-7
pubmed: 10483949
JACC Cardiovasc Interv. 2013 Sep;6(9):897-904
pubmed: 24050858
J Am Coll Cardiol. 2016 Apr 12;67(14):1715-22
pubmed: 27056778

Auteurs

Georg Wolff (G)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany. georg.wolff@med.uni-duesseldorf.de.

Yingfeng Lin (Y)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Julia Quade (J)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Selina Bader (S)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Lucin Kosejian (L)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Maximilian Brockmeyer (M)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Athanasios Karathanos (A)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Claudio Parco (C)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Torben Krieger (T)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Yvonne Heinen (Y)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Stefan Perings (S)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Alexander Albert (A)

Clinic for Cardiovascular Surgery, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.

Andrea Icks (A)

Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Institute for Health Services Research and Health Economics, German Diabetes Centre, Düsseldorf, Germany.
German Institute for Diabetes Research, Neuherberg, Munich, Germany.

Malte Kelm (M)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.
CARID-Cardiovascular Research Institute, Düsseldorf, Germany.

Volker Schulze (V)

Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Medical Faculty, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH